Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilanterol versus salmeterol versus placebo in persistent asthma uncontrolled on inhaled corticosteroids
2010-020412-11Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vilanterol in persistent asthma (3 arms), sponsored by GSK. Primary endpoint: Change from baseline in weighted mean serial FEV1 over 0-24 hours at week 12. Started Jul 2010; status: completed.
02
Drugs
vilanterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2010-020412-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020412-11.